#USA #New York #Class Action #Faruqi & Faruqi #Savara Inc.

Savara Investors Take Note: Class Action Lawsuit Deadline Approaching

Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims against Savara Inc. (NASDAQ: SVRA). With a critical lead plaintiff deadline approaching on November 7, 2025, investors who have sustained losses exceeding $50,000 between March 7, 2024, and May 23, 2025, are encouraged to consider their legal options. This opportunity arises amidst a class action lawsuit filed against Savara, highlighting serious allegations about the company's transparency and regulatory compliance.

The Basis of the Claims

The legal action stems from claims that Savara and its executives allegedly contravened federal securities laws. Key allegations include:
1. The failure to provide adequate information about the MOLBREEVI Biologics License Application (BLA), specifically concerning its chemistry and manufacturing processes.
2. The likelihood that the FDA would reject the MOLBREEVI BLA in its current form.
3. An indicated delay in submitting the application within the timeline previously communicated to investors.
4. Apossible requirement for Savara to secure additional capital, exacerbated by the delay in regulatory approvals.
5. Public statements from Savara were therefore materially misleading and false.

The situation escalated on May 27, 2025, when Savara issued a press release disclosing a refusal to file letter from the FDA regarding the BLA for MOLBREEVI, intended to treat autoimmune PAP (pulmonary alveolar proteinosis) patients. This announcement led to a staggering 31.69% decline in Savara's stock price, dropping from about $2.84 to $1.94 per share.

The Role of Lead Plaintiff

In class action litigation, the lead plaintiff is an investor who has the most significant financial stake in the claims of the class and is representative of typical class members. Interested parties can apply to be appointed as the lead plaintiff through their legal counsel or opt to remain as an absentee class member, with no impacts on their ability to benefit from any potential recovery. This legal framework ensures that investor rights are upheld and that oversight of the class action is appropriately managed.

How to Get Involved

Faruqi & Faruqi’s Senior Partner, Josh Wilson, has urged any affected investors to contact him directly to discuss their situation and legal rights. Interested parties can reach out via the firm's dedicated contact numbers, emphasizing the importance of timely action given the pressing deadline.

Additionally, the firm invites individuals with insights into Savara's conduct, such as whistleblowers or former employees, to come forward and provide information that may aid the investigation.

For further details regarding the Savara class action lawsuit, visit Faruqi Law's website or contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). The firm's established history of recovering substantial amounts for investors adds a layer of reassurance for those considering their legal options.

Conclusion

As the class action lawsuit progresses and the November deadline approaches, it’s imperative for Savara investors who feel aggrieved to understand their rights and options available to them. With Faruqi & Faruqi’s guidance, investors can navigate this turbulent landscape and work towards reclaiming potential losses incurred during the period of the alleged misconduct.

Disclaimer: This article constitutes attorney advertising. Prior results do not guarantee a similar outcome for future matters. All communications with Faruqi & Faruqi will be confidential.